Monocyclic N-Aryl hydantoin modulators of androgen receptor function
US7256208B2 · kind B2 · utility
7Cited by
8References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2004 |
| Grant date | Aug 14, 2007 |
| Priority date | — |
| Expiry date | Jun 29, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D233/96
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel compounds useful in the treatment of androgen receptor associated conditions, such as age-related diseases, pharmaceutical compositions containing at least one of the compounds of the present invention and methods of treating a patient in need of therapy for an androgen receptor associated condition by administering a therapeutically effective amount of at least compound of the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.